Lexeo Therapeutics, Inc. (LXEO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$98.56M | -21.5% |
| 2024 | -$81.15M | -36.4% |
| 2023 | -$59.50M | -9.0% |
| 2022 | -$54.56M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$98.56M | -21.5% |
| 2024 | -$81.15M | -36.4% |
| 2023 | -$59.50M | -9.0% |
| 2022 | -$54.56M | — |